vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and WATSCO INC (WSO). Click either name above to swap in a different company.
WATSCO INC is the larger business by last-quarter revenue ($1.6B vs $829.0M, roughly 1.9× Acadia Healthcare Company, Inc.). WATSCO INC runs the higher net margin — 4.5% vs 0.5%, a 4.0% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -10.0%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs 0.4%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Watsco, Inc. is a distributor of air conditioning, heating and refrigeration equipment, and related parts and supplies (HVAC/R) in the United States. Watsco was founded more than 60 years ago as a manufacturer of parts, components, and tools used in the HVAC/R industry. In 1989, the company shifted from manufacturing to distribution, by acquiring Gemaire Distributors Inc., a South Florida-based Rheem distributor.
ACHC vs WSO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.6B |
| Net Profit | $4.5M | $71.7M |
| Gross Margin | — | 27.1% |
| Operating Margin | — | 6.4% |
| Net Margin | 0.5% | 4.5% |
| Revenue YoY | 7.5% | -10.0% |
| Net Profit YoY | -50.8% | -25.9% |
| EPS (diluted) | $0.05 | $1.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.6B | ||
| Q3 25 | $851.6M | $2.1B | ||
| Q2 25 | $869.2M | $2.1B | ||
| Q1 25 | $770.5M | $1.5B | ||
| Q4 24 | $774.2M | $1.8B | ||
| Q3 24 | $815.6M | $2.2B | ||
| Q2 24 | $796.0M | $2.1B |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $71.7M | ||
| Q3 25 | $36.2M | $161.6M | ||
| Q2 25 | $30.1M | $183.6M | ||
| Q1 25 | $8.4M | $80.1M | ||
| Q4 24 | $32.6M | $96.8M | ||
| Q3 24 | $68.1M | $171.0M | ||
| Q2 24 | $78.5M | $181.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.1% | ||
| Q3 25 | — | 27.5% | ||
| Q2 25 | — | 29.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 26.7% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.1% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 6.4% | ||
| Q3 25 | 4.7% | 11.4% | ||
| Q2 25 | 5.8% | 13.2% | ||
| Q1 25 | 1.7% | 7.3% | ||
| Q4 24 | 4.9% | 7.8% | ||
| Q3 24 | 12.1% | 11.6% | ||
| Q2 24 | 13.4% | 12.6% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 4.5% | ||
| Q3 25 | 4.3% | 7.8% | ||
| Q2 25 | 3.5% | 8.9% | ||
| Q1 25 | 1.1% | 5.2% | ||
| Q4 24 | 4.2% | 5.5% | ||
| Q3 24 | 8.4% | 7.9% | ||
| Q2 24 | 9.9% | 8.5% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.82 | ||
| Q3 25 | $0.40 | $3.98 | ||
| Q2 25 | $0.33 | $4.52 | ||
| Q1 25 | $0.09 | $1.93 | ||
| Q4 24 | $0.36 | $2.42 | ||
| Q3 24 | $0.74 | $4.22 | ||
| Q2 24 | $0.85 | $4.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $733.3M |
| Total DebtLower is stronger | $2.5B | $361.6M |
| Stockholders' EquityBook value | $2.0B | $2.8B |
| Total Assets | $5.5B | $4.4B |
| Debt / EquityLower = less leverage | 1.29× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $733.3M | ||
| Q3 25 | $118.7M | $524.3M | ||
| Q2 25 | $131.4M | $293.0M | ||
| Q1 25 | $91.2M | $431.8M | ||
| Q4 24 | $76.3M | $781.9M | ||
| Q3 24 | $82.1M | $550.0M | ||
| Q2 24 | $77.2M | $424.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $361.6M | ||
| Q3 25 | $2.3B | $340.8M | ||
| Q2 25 | $2.3B | $338.7M | ||
| Q1 25 | $2.2B | $346.4M | ||
| Q4 24 | $2.0B | $337.2M | ||
| Q3 24 | $1.9B | $321.0M | ||
| Q2 24 | $1.8B | $307.1M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.8B | ||
| Q3 25 | $3.1B | $2.8B | ||
| Q2 25 | $3.1B | $2.8B | ||
| Q1 25 | $3.0B | $2.7B | ||
| Q4 24 | $3.1B | $2.7B | ||
| Q3 24 | $3.0B | $2.7B | ||
| Q2 24 | $3.0B | $2.6B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $4.4B | ||
| Q3 25 | $6.4B | $4.6B | ||
| Q2 25 | $6.3B | $4.7B | ||
| Q1 25 | $6.1B | $4.5B | ||
| Q4 24 | $6.0B | $4.5B | ||
| Q3 24 | $5.9B | $4.5B | ||
| Q2 24 | $5.7B | $4.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.13× | ||
| Q3 25 | 0.74× | 0.12× | ||
| Q2 25 | 0.74× | 0.12× | ||
| Q1 25 | 0.72× | 0.13× | ||
| Q4 24 | 0.64× | 0.13× | ||
| Q3 24 | 0.62× | 0.12× | ||
| Q2 24 | 0.62× | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $399.8M |
| Free Cash FlowOCF − Capex | — | $388.5M |
| FCF MarginFCF / Revenue | — | 24.6% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | 13.78× | 5.57× |
| TTM Free Cash FlowTrailing 4 quarters | — | $535.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $399.8M | ||
| Q3 25 | $73.2M | $354.9M | ||
| Q2 25 | $133.5M | $-7.4M | ||
| Q1 25 | $11.5M | $-177.6M | ||
| Q4 24 | $116.7M | $378.9M | ||
| Q3 24 | $163.1M | $232.8M | ||
| Q2 24 | $171.1M | $57.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $388.5M | ||
| Q3 25 | $-63.0M | $346.1M | ||
| Q2 25 | $-34.2M | $-14.3M | ||
| Q1 25 | $-163.2M | $-185.2M | ||
| Q4 24 | $-86.8M | $370.9M | ||
| Q3 24 | $-27.1M | $223.0M | ||
| Q2 24 | $16.9M | $51.3M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 24.6% | ||
| Q3 25 | -7.4% | 16.7% | ||
| Q2 25 | -3.9% | -0.7% | ||
| Q1 25 | -21.2% | -12.1% | ||
| Q4 24 | -11.2% | 21.1% | ||
| Q3 24 | -3.3% | 10.3% | ||
| Q2 24 | 2.1% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.7% | ||
| Q3 25 | 16.0% | 0.4% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.5% | ||
| Q4 24 | 26.3% | 0.5% | ||
| Q3 24 | 23.3% | 0.5% | ||
| Q2 24 | 19.4% | 0.3% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 5.57× | ||
| Q3 25 | 2.02× | 2.20× | ||
| Q2 25 | 4.43× | -0.04× | ||
| Q1 25 | 1.37× | -2.22× | ||
| Q4 24 | 3.58× | 3.91× | ||
| Q3 24 | 2.39× | 1.36× | ||
| Q2 24 | 2.18× | 0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
WSO
Segment breakdown not available.
